ADI
70
-6
PRU
62
-18
DHR
62
-2
SYK
28
-31
VRTX
49
-16
LYB
23
3
BEN
53
3
ORCL
24
-4
PLD
32
-19
MDT
55
2
AFL
46
4
CAT
64
-5
LB
33
11
EMR
59
-5
NEE
50
-4
RRC
62
-16
BXP
38
-4
JBHT
60
-3
HAL
50
3
AIZ
76
13
ADI
70
-6
PRU
62
-18
DHR
62
-2
SYK
28
-31
VRTX
49
-16
LYB
23
3
BEN
53
3
ORCL
24
-4
PLD
32
-19
MDT
55
2
AFL
46
4
CAT
64
-5
LB
33
11
EMR
59
-5
NEE
50
-4
RRC
62
-16
BXP
38
-4
JBHT
60
-3
HAL
50
3
AIZ
76
13
Financhill
Back

Probe Gold, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
62

PROBF
Probe Gold, Inc.

Last Price:
$2.64
Seasonality Move:
24.14%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$65.70
Seasonality Move:
25.93%
Buy
62
Probe Gold, Inc. (PROBF) is a Buy

Is Probe Gold, Inc. a Buy, Sell or Hold?

  • The current Probe Gold, Inc. [PROBF] share price is $2.63. The Score for PROBF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • PROBF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $67.70. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PROBF Stock Price Chart

What is Probe Gold, Inc.'s stock price today?

  • The Probe Gold, Inc. share price today is $2.63
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PROBF is experiencing selling pressure, which indicates risk of future bearish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $67.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.

PROBF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 60.12 Buy
Chaikin Money Flow: -220949 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.58 - 2.66) Buy
Bollinger Bands (100): (1.78 - 2.52) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.86 Sell
Relative Strength Index (14 RSI): 33.87 Sell
Chaikin Money Flow: -124010 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (74.34 - 86.38) Sell
Bollinger Bands (100): (44.81 - 88.99) Buy

PROBF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.65 Sell
20-day SMA: 2.62 Buy
50-day SMA: 2.41 Buy
200-day SMA: 1.85 Buy
8-day EMA: 0.59 Buy
20-day EMA: 0.25 Buy
50-day EMA: 0.1 Buy
200-day EMA: 0.03 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 74.5 Sell
20-day SMA: 80.22 Sell
50-day SMA: 82.77 Sell
200-day SMA: 51.96 Buy
8-day EMA: 74.03 Sell
20-day EMA: 77.79 Sell
50-day EMA: 77.58 Sell
200-day EMA: 56.47 Buy

Probe Gold, Inc. Earnings Growth & PROBF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Probe Gold, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):